MapLight Therapeutics, Inc. (MPLT) Institutional Ownership and Insiders Activity
MapLight Therapeutics, Inc. (MPLT) is widely held by institutional investors, with 102 firms reporting positions valued at approximately $941.38M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Novo Holdings A/S is the largest disclosed holder, reporting approximately $132.13M in MPLT holdings in its latest filing.
Recent insider activity includes 6 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
102
Total Reported Value
$941.38M
Largest Holder
Novo Holdings A/S
Largest Position
$132.13M
Insider Transactions (90d)
6
Latest Filing Quarter
Q2 2026
New Institutional Positions
37
Funds Exiting Positions
13
Top Institutional Owners
View allInvestorReported Balance
- Novo Holdings A/S$132.13M
- Fcpm Iii Services B.V.$115.63M
- T. Rowe Price Investment Management, Inc.$99.70M
- Goldman Sachs Group Inc$69.83M
- Price T Rowe Associates Inc$51.00M
Related MPLT Institutional Insights:
- MPLT 13F Institutional Holders
- MPLT Superinvestors
- MPLT Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- MPLT Insider Trading & SEC Form 4 Activity
- MPLT Articles
- Top Institutional Investor Stock Rankings